Airway Clearance Using High Frequency Chest Wall Oscillation
NCT ID: NCT00817947
Last Updated: 2009-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
30 participants
INTERVENTIONAL
2007-01-31
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: In people with cystic fibrosis 'The Vest' will lead to the expectoration of an increased weight of sputum during treatment sessions compared with alternative airway clearance regimens.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HFCWO in Prolonged Mechanical Ventilation Patients
NCT02077738
HFCWO on Pneumonic Respiratory Failure
NCT02758106
Non Invasive Ventilation for Acute Exacerbations in Adult CF
NCT02234401
VICOR Study-High Frequency Chest Wall Oscillations (HFCWO) in Patients With Acute Respiratory Failure and Hypersecretion
NCT05751707
Comparison of a Hyperinflation Mode and Air Stacking on Neuromuscular Patients Under Volumetric Ventilation
NCT02847299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual airway clearance technique
Airway clearance using the active cycle of breathing techniques, autogenic drainage, positive expiratory pressure or oscillating positive expiratory pressure
High frequency chest wall oscillation
Airway clearance using high frequency chest wall oscillation ('The Vest')
HFCWO
High frequency chest wall oscillation
High frequency chest wall oscillation
Airway clearance using high frequency chest wall oscillation ('The Vest')
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High frequency chest wall oscillation
Airway clearance using high frequency chest wall oscillation ('The Vest')
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 16 years of age or over
* forced expiratory volume in one second greater than or equal to 25 percent of predicted
* hospitalised patients in a stable clinical state
Exclusion Criteria
* rib fractures
* pregnancy
* inability to give consent
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Royal Brompton & Harefield NHS Trust
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer A Pryor, PhD
Role: PRINCIPAL_INVESTIGATOR
Royal Brompton & Harefield NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Brompton Hospital
London, London, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06/Q0404/54
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.